FDA recall Z-2199-2021

Stanbio Laboratory, LP · Class III · device

Product

Beta-Hydroxybutyrate LiquiColor. in vitro diagnostic reagent.

Reason for recall

Deterioration in the stability of the reagents which has resulted in lower than expected or out of range Quality Control values.

Distribution

Worldwide distribution - U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, MI, MO, NC, NH, NJ, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, TN, TX, VA, VT, WA, WI, and WV. The countries of Australia, Canada, Chile, Federal Republic of Germany, Hong Kong, Singapore, Taiwan, Thailand, United Kingdom, and Viet Nam.

Key facts

Status
Terminated
Initiation date
2021-07-12
Report date
2021-08-11
Termination date
2022-03-29
Voluntary/Mandated
Voluntary: Firm initiated
Location
Boerne, TX, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2199-2021